Atin Goyal
Founder and Managing Director of Caerus Global Pty Ltd
With over 18 years of diverse global experience, Atin is a seasoned Pharmacovigilance expert. He has accumulated over 14 years of expertise in Pharmacovigilance, contributing to major pharmaceutical companies such as Eli Lilly, Novartis, GSK, Haleon, Samsung Bioepis, and regulatory authority MHRA.
As the Founder and Managing Director of Caerus Global Pty Ltd, He has spearheaded techno-functional services and successfully partnered with Commonwealth Informatics Inc. (CII) to implement a Signal Management solution system (CVW) for Samsung Bioepis in South Korea. Currently, He is actively involved in implementing signal management solutions for Haleon and the UK regulatory authority - MHRA. Along with the partner company, he is currently working on a pioneering software solution for Medical Devices signal management for MHRA.
Additionally, at Caerus Global, he initiated the development of ConvertPV, a proprietary product - ICSR E2B R2 to R3 report conversion tool, providing valuable assistance to pharmaceutical companies and regulators transitioning to R3 standards for electronic report submission.
Driven by a passion for advancing Pharmacovigilance, he continues to lead innovative initiatives at Caerus Global, ensuring seamless transitions to industry standards and contributing to the evolution of pharmaceutical safety practices.